International Journal of Dermatology 1995: Vol 34 Index

17 Pages·1995·3.2 MB·English

CUMULATIVE INDEX: VOLUME 34
ee
SUBJECT INDEX Age Anetoderma, 408-414
and gender differences in psoriasis Anetodermic cutaneous changes, 144
Abscess, 385-386 impact, 700-703 Angiogenesis, 7-8
Acantholytic disorders See also Old age Angiolymphoid hyperplasia, 267-269
dermatoses, 113, 754 Aging, cutaneous, 546-549 Angiosarcoma, 773
hypopigmented macules, 390-392 AIDS (acquired immunodeficiency Angiotensin converting enzyme (ACE),
Acanthosis nigricans, 753, 754, 867-869 syndrome) 151-152
ACE. See Angiotensin converting cutaneous aspergillosis in, 551-552 Angular cheilitis, 760, 761, 763
enzyme cutaneous histoplasmosis in, Angular stomatitis, 760, 763
Acetaminophen, 220-221 558-561 Animal testing, 273, 389, 541, 710
Acne fungal infections in, 287-288
Anthralin, 677-678
cosmetic, 369-370 ichthyosis and, 752
Antibodies
postadolescent, 372 Kaposi’s sarcoma related to, 729-731
alopecia areata and, 542-545
rosacea, 236 Leishmania braziliensis in, 114-115,
anticardiolipin, 408-414
scars, 53-56 303-306
Anticardiolipin antibodies, 408-414
in systemic lupus erythematosus, mucocutaneous manifestations and,
Anticoagulants, 152
338-340 416-419
Antidepressants, 154-155
vulgaris, 53-56, 80-82, 369-370, periungual telangiectasias in,
Antidermatophytic activity, 278-279
372, 434-437 199-200
Acquired immunodeficiency syndrome See also HIV Antifungal drugs, 284-285
See AIDS Albendazole, 574-578 Antineoplastic agents, 152
Acquired paraneoplastic syndromes, ALCL. See Anaplastic large cell Antisense oligodeoxynucleotides, 603
752-755 lymphoma Antithyroid drugs, 152
Acquired port-wine stains, 48-52 Alcohol, 401 Antithyroid thioureylenes, 280-282
Acquired psoriasis, 448-449 Alcoholic liver cirrhosis, 651-652 Antiviral agents, 597-604
Acrodermatitis enteropathica (AE), 15 Allergenic extracts, 118, 555 Aplasia, 590
Acrokeratoelastoidosis of Costa, Allium sativum. See Garlic APN. See Acrokeratosis paraneoplastica
431-433 Allylamines, 615 Aquatic dermatitis, 765
Acrokeratosis paraneoplastica (APN),
Alopecia Ara-C, 470-472
719, 753
androgenic, 150 Arsenic, 260
Acrospiroma, 271-273
drug-induced, 149-156, 470-472 Arthritis, 148
Actinic prurigo, 363-364, 380-383
Alopecia areata, 542-545 Aspergillosis, 551-552
Acute atrophic candidosis. See
Alpha-tocopherol, 508 Aspergillus, 521, 523, 529, 551-552
Erythematous candidosis
Alternariosis, 556-557 Atabrine, 158
Acute febrile neutrophilic dermatosis.
See Sweet’s syndrome Alveolar bronchiolar carcinoma, Ataxia-telangiectasia, 751-752
867-869 Atopic dermatitis, 294, 381
Acute myelogenous leukemia (AML),
755 Amelanosis, 595-596 herpes simplex virus in, 854-856
Acute pseudomembranous candidosis. American histoplasmosis, 743 Atrophic acne scars, 53-56
See Oral thrush Amiodarone, 151 Atrophic candidosis, 760, 762
Acyclovir, 597-598 AML. See Acute myelogenous leukemia Autoantibodies, 591-592
Adenocarcinoma, 360-362 Amphotericin B, 764 Autoerythrocyte sensitization syndrome,
Adhesion molecules, 3-6, 510-512 Amyloidosis, 754 373
Adiposis dolorosa. See Dercum’s disease Anagen effluvium, 150 Autoimmune progesterone dermatitis,
Adult-onset dermatomyositis, 754 Anaphylaxis, 572-573 372-373
Adult-onset Still’s disease, 490-492 Anaplastic large cell lymphoma (ALCL), Avitaminosis A, 14
AE. See Acrodermatitis enteropathica 790-793 Avitaminosis B, 14-15
African Kaposi’s sarcoma, 166-167, Androgenic alopecia, 150 AZA. See Azelaic acid
729-731 Androgen-related skin diseases, 720-724 Azelaic acid (AZA), 75-82
Agammaglobulinemia, 752 Anemia, 751 Azidothymidine, 600-601
International Journal of Dermatology
Vol. 34, No. 12, December 1995
Bacitracin, 572-573 Biology of the Epidermis: Molecular Callus, 213
Bacteria, 461-463 and Functional Aspects, 748 Cancer
Basal cell carcinoma Clinical Signs and Procedures in extramammary Paget’s disease and,
in black population, 517-518 Dermatology, 148 715-716
histologic subtypes of, 174-176 Color Guide Dermatology, 22 skin, 445-447, 466-469, 770-776
interferon and, 58-59 Common Skin Disorders, 520 See also Carcinoma; Malignancy;
Cutaneous Surgery, 672 Tumors; specific types of cancer
lifestyle and, 398-401
linear, 488 Differential Diagnosis in Candida, 521-522, 529, 551, 608,
Dermatopathology IV, 74 759-762
nevoid, 750
An Illustrated Dictionary of Candida albicans, 522, 529, 759-763
perianal, 427
Dermatologic Syndromes, 824 Candidal leukoplakia, 760-761, 763
in Singapore, 770-772
Liposomes: From Physics to Candidosis
tumor size and, 319-320 Applications, 748
chronic atrophic, 760, 762
Basement membrane phenomenon, Modern Treatment for
chronic multifocal, 761
330-332 Lymphoedema, 748
oral, 759-764
Bathing Occupational Skin Disorders, 367
Capsaicin, 594-595, 679
in ancient times, 25 Physical Signs in Dermatology, 444
Carbuncles, 359
cold water, 35, 202 Unwanted Effects of Cosmetics and
Carcinoma
general, 167, 180, 185, 192, 200, Drugs Used in Dermatology,
479, 532 36 - alveolar bronchiolar, 867-869
laws of, 173 Year Book of Dermatologic Survey cutaneous metastatic
adenocarcinoma, 360-362
as therapy, 29 1993, 222
Bazex syndrome. See Acrokeratosis Boric acid dermatitis, 633 eccrine, 859-860
paraneoplastica Bosnia, medical needs in, 883-884 gastric, 713-714
hepatocellular, 755
Beerman, Herman, 746-747 Bowen’s disease, 116-117, 770-772, 7
Behcet’s disease Brazil, cutaneous leishmaniasis in, scirrhous, 293-294
cutaneous manifestations of, 159-163 474-478 See also Basal cell carcinoma; Cancer;
Squamous cell carcinoma
immune complexes in, 841-844 Breast, malignant eccrine acrospiroma
of, 271-273 Cardol, 72-73
purpuric papulonodular lesions and,
Breast feeding, 121 Cationic protein, 177-179
190-192
Bromocriptine, 153 Cellular enzymes, 76
Benign juvenile melanoma. See Spitz
Bronchiolar carcinoma, 867-869 Cerebriform intradermal nevus, 634
nevus
Benzoic acid, 716 Bruton’s X-linked agammaglobulinemia, Cerebrospinal fluid (CSF), 73-74
Berger’s disease, 794-795 752 Cervantes, Miguel, 212-215
Berliner, Paul, 817 Bucillamine, 493-494 Cetirizine, 510-512
Beta-blockers, 152, 450-451 Bullous dermatosis, 754 CGRP. See Calcitonin-gene-related
Bullous larva migrans, 570-571 peptide
Beta-carotene, 400
Bullous pemphigoid, 7, 745 Chediak-Higashi syndrome, 751
Bethencourt, Jacques de, 124
burn-induced, 516-517 Cheilitis, 760, 761, 763
Bifonazole
eosinophil cationic protein in, Chemotherapy, 729-731
for onychomycosis, 500-502
177-179 Children
for tinea versicolor, 614
Burning mouth syndrome, 483-487 condylomata acuminata in, 298-299
Biotin, 15-16
Burns lymphomas and leukemias in,
Birthmarks, 704-706
boiling milk, 707-709 249-255
Black population, 517-518
bullous pemphigoid induced by, vitiligo in, 203-205
Blaschko’s lines, 482 $16-517 Cholera, 195
Bloch, Iwan, 424
from diquat and paraquat, 23-24 Chromatography, 63-64
Bloom’s syndrome, 751 BV-ara-U, 602 Chromoblastomycosis, 804-807
Blue coloring, 430, 509
Chronic atrophic candidosis, 760, 762
Body weight, 401 Café-au-lait spots, 704-706 Chronic hyperplastic candidosis. See
Boiling milk burn, 707-709 Caffeine, 401 Candidal leukoplakia
Bone density, 733-734 Calcipotriene, 676-677 Chronic interstitial pneumonitis,
Book Reviews Calcitonin-gene-related peptide (CGRP), 354-355
Advances in Dermatology, 672 686-690, 694 Chronic multifocal candidosis, 761
886
Subject Index
Chronic photocontact dermatitis, 381 Cutaneous histoplasmosis, 558-561 chronic photocontact, 381
Chronic urticaria, 823-824 Cutaneous hypopigmentation, 824 contact, 369-370
Chronic venous hypertension (CVH), Cutaneous leishmaniasis rhus, 769, 789
696-698 diffuse, 474-478 seborrheic, 213
Churchill, Sir Winston, 665 itraconazole for, 295 tincture of benzoin, 716
CIC. See Circulating immune complexes ketoconazole for, 120-121, 495-497 Dermatobia hominis, 624-626
Cicatricial pemphigoid, 639-641 recurrent, 129-132 Dermatofibrosarcoma protuberans,
Ciliated cyst, 32 Cutaneous leukocytoclastic vasculitis. 256-259
Cimetidine, 153 See Hypersensitivity vasculitis Dermatologic moulage. See Moulage
Circulating immune complexes (CIC), Cutaneous lupus erythematosus, Dermatology
841-844
354-355, 480-482 gender and tropical diseases, 226-234
Cirrhosis, 651-652 Cutaneous lymphoma, 535-537, in India, 322
Clindamycin, 434-437 622-623, 772-773 psychiatry and, 244-248
Clobetasol propionate cream, 203-205 Cutaneous metastases, 749-750 Tibetan medicine and, 834-836
Clotrimazole, 763 Cutaneous metastatic adenocarcinoma, women in, 221-222
Coal tar, 553 360-362 387-389, 531-532
drugs from, 169 Cutaneous microflora, 76 Dermatomycoses, 125-128, 286, 754
for skin disease, 60 Cutaneous myiasis, 624-626 Dermatomyositis, 754, 797-798
Coccidiodomycosis, 743 Cutaneous neuropeptides, 685-690 Dermatopathia pigmentosa reticularis,
Colchicine, 153 Cutaneous protothecosis, 554-555, 645-646
Cold bath, 35, 202 766-767 Dermatoses
Cutaneous toxoplasmosis, 443 erosive pustular, 148
Collagenosis, 196-197
Cutaneous tuberculosis, 26-29 genetic, 750-752
Coma-induced epidermal necrolysis,
CVH. See Chronic venous hypertension inflammatory, 308-309
801-803
Cyclophosphamide, 875-882 linear IgA, 591-592
Complexion, 657, 693, 803
Condylomata acuminata, 209-211, Cyclosporine neutrophilic, 323-328, 797-798
297-300 for cicatricial pemphigoid, 639-641 nutritional, 11-16
Condylomata lata, 242 for psoriasis, 583-588 reticulate pigmentary, 30-31
Confluent papillomatosis, 567-568 topical, 678-679 transient acantholytic, 113
Congenital nevi, 704-706, 825-828, Cyst, 32 Dexamethasone
863-864 Cysticercosis, 574-578, 652 for pemphigus, 875-882
Congenital nevus pigmentosus, 863-864 Cytodestructive agents, 299 in progressive systemic sc lerosis,
726-728
Conjunctival melanomas, 349-353 Cytokine receptors, 3
Didanosine, 601
Contact dermatitis, 369-370, 381
Diday, Paul, 115
Contraceptives, 154 Dapsone, 870-871
Diffuse dermal neutrophilia, 797-798
Cordylobia anthropophaga, 624-626 Dead Sea Psoriasis Clinic, 134-136
Diquat, 23-24
Corticosteroids, 673-676 Deaths, from allergenic extracts, 118, 555
Direct immunofluorescence, 480-482
Cosmetic-acne cosmetica, 369-370 Deep mycoses, 742-744
Dirofilaria (Nochtiella) repens, 274-276
CO) laser, 42-47, 209-211 Denture hygiene, 760, 762-763
Dirofilariasis, 274-276
Cowden’s syndrome, 750 Denture sore mouth, 760
Discoid lupus erythematosus (DLE)
Creseis acicula, 765 Denture stomatitis, 760
lesions, 357-358
Croatia, medical needs in, 883-884 Depilatories, 337
lupus band test in, 170-173
Crohn’s disease, 670-671, 830-831 Dercum’s disease, 375-376
Disseminated pyogenic granuloma,
Cryotherapy, 300, 804-807 Dermal fibroblasts, 720-724
707-709
Cryptococcosis, 743 Dermal nerves, 837-840
Disseminated superficial actinic
CSF. See Cerebrospinal fluid Dermal neutrophilia, 797-798
porokeratosis (DSAP), 71-72
Curettage, 300 Dermatitis, 8, 318 DLE. See Discoid lupus erythematosus
Cutaneous alternariosis, 556-557 aquatic, 765 Dohi, Keizo, 817-818, 820
Cutaneous aspergillosis, 551-552 artefacta, 370
Don Quixote, 212-21
Cutaneous ciliated cyst, 32 ato29p4, 3i81,c 85,4-8 56 Drugs
Cutaneous endometriosis, 261-262 autoimmune progesterone, 372-373 alopecia induced by, 149-156,
Cutaneous fungal infections, 284-288 boric acid, 633 470-472
International Journal of Dermatology
Vol. 34, No. 12, December 1995
antifungal, 284-285 Exanthem, 119 Giant disseminated pyogenic granuloma,
antithyroid, 152 Exanthematous pustulosis, 263-265 707-709
development process of, 94-95 Exophiala jeanselmei, 563-565 Glossitis, 761, 763
exanthematous pustulosis induced Extramammary Paget’s disease (EMPD), Glucagonoma syndrome, 753
by, 263-265 715-716, 750, 773 Gold, 153
from coal tar, 169 Gorlin’s syndrome. See Nevoid basal cell
history of eruptions, 767 Famciclovir, 598-599 carcinoma syndrome
multiple, 666-668 Fanconi’s anemia, 751 Granuloma
salicylic acid and, 664 Fat, 401 anaplastic large cell lymphoma as,
toxic shock syndrome and, 661-663 Fernel, Jean, 270 790-793
See also specific drugs Fibroblasts, 720-724 annulare, 40-41
DSAP. See Disseminated superficial Fibrosis, 6-7 Majocchi’s, 489
actinic porokeratosis Finasteride, 720-724 pyogenic, 707-709
Dyskeratosis congenita, 752 Fish-odor syndrome, 92-93 Granulomatosis
5a-reductase activity, 720-724 orofacial, 830-832
EAC. See Erythema annulare 5—Fluorouracil, 219-220 Wegener’s, 870-871
centrifugum
Flesh-eating bacteria, 461-463 Granulomatous inflammations, 242
Eccrine acrospiroma, 271-273
Fluconazole Group-A streptococcal infection,
Eccrine carcinoma, 859-860
for oral candidosis, 762-763 461-463, 642-644
Eccrine poroma, 857-858
for tinea versicolor, 498-499, 614 Growth factor, 293-294
Ecthyma gangrenosum, 216-217
Flucytosine, 764
Eczema, 356 Fluoxetine, 153 Habit tic deformity, 799-800
EGR. See Erythema gyratum repens Flushing, 375 Hair
Ehrlichia canis, 618-619 Follicular mucinosis, 867-869 removal of superfluous, 337
Ehrlichiosis, 618-619
Fonsecaea pedrosoi, 804-807 See also Alopecia
882C87 analog, 602-603
Forearm, 859-860 Hairy leukoplakia, 420-423
Elderly. See Old age
Foscarnet sodium, 600 Hasegawa, Kentaro, 818-820
Electrodesiccation, 300 Fournier, Alfred, 428 Hawaiians, keratoacanthoma in, 851-853
EMPD. See Extramammary Paget’s
Fracastoro, Girolamo, 735-739 “Health for All” programs, 230-231
disease
Friar’s balsam, 716 Health policy, 229
Endocrine neoplasia, 751
Endometriosis, 261-262 Fulminant head, 622-623 Helicobacter pylori, 236
Eosinophil cationic protein, 177-179 Fungal infections Hemangioendothelioma, 811-815
Eosinophilia, 267-269 in AIDS, 287-288 Hemangiomas, 705-706
cutaneous, 284-288 Hemochromatosis, 752
Epidermal growth factor, 293-294
Fungicidal agents, 285-286 Hemodialysis, 546-549
Epidermal necrolysis, 801-803, 816
Fungistatic agents, 285-286 Hemolytic streptococcal infection,
Epithelial germ, 782-785
642-644
Fungitoxic agents, 285-286
Epstein-Barr virus, 761
Hendersonula toruloidea, 521, 523
Erosive pustular dermatosis, 148
Gallbladder, 360-362 Henning, Carl, 817
Erythema annulare centrifugum (EAC),
752-753 Ganciclovir, 599 Heparan sulfate proteoglycan, 630-632
Erythema gyratum repens (EGR), 753 Gardner’s syndrome, 751 Heparin, 443-444
Erythematous candidosis, 760 Garlic, 278-279 Hepatitis C, 823-824
Erythematous exanthem, 119 Gastric carcinoma, 713-714 Hepatocellular carcinoma, 755
Erythermalgia, 97-99 Gender Hepatotoxicity, 589
Erythroderma, 755 in psoriasis, 700-703 Heroic therapy, 537
Erythromelalgia, 97-99, 146 and tropical diseases, 226-234 Herpes simplex virus
Esthetic techniques, 375 See also Women in atopic dermatitis, 854-856
Estriol, 53-56 Genetic dermatoses, 750-752 in women, 370-371
Etretinate, 645-646 Genodermatoses, 369, 750-752 Hickman catheter, 551-552
European Society of Dermatological German Dermatological Association, Histiocytosis, 106-111
Research Symposium (Aarhus, 38th Congress (Berlin), 822 Histoid leprosy, 777-781
Denmark), 740 Germ theory, 69 Histoplasma capsulatum, 743
Subject Index
Histoplasmosis, 558-561, 743 IgA nephropathy. See Berger’s disease Japan
Hives, 359 IgE receptor, 5 dermatologic moulage in, 817-820
HIV infection, 308-315 IL-2. See Interleukin-2 systemic lupus erythematosus in,
anetoderma in, 408-414 IL-4. See Interleukin-4 333-336
breast feeding and, 121 Imiquimod, 603 Japanese Hawaiians, keratoacanthoma
hairy leukoplakia in, 420-423 Immune complexes, 841-844 in, 851-853
malignant syphilis and, 403-406 Immunofluorescence, 480-482 Juvenile xanthogranuloma, 653-655
mucocutaneous manifestations and, Immunoglobulin receptors, 3
416-419 Immunoglobulins, 602 Kaposi's lectures, 871
oral candidosis in, 761-764 Impotence, 712 Kaposi's sarcoma, 754, 773
seroconversion syndrome, 238-239 African, 166-167, 729-731
India, community dermatology in, 322
in women, 371 AIDS-related, 729-731
Induced psoriasis, 449-451
See also AIDS Infections Kaposi’s varicelliform eruption,
Hodgkin’s lymphoma, 752, 755 854-856
fungal, 284-288
Hong Kong, cutaneous tuberculosis in, Kauai, Hawaii
streptococcal, 461-463, 642-644
26-29 keratoacanthoma in, 851-853
Infectious mononucleosis, 220-221
Hormone replacement therapy, 375 squamous cell carcinoma in, 393-397
Inflammatory dermatomycoses, 125-128
Howel-Evans-Clark syndrome, 751 Keloids, 506-509
Inflammatory dermatoses, 308-309
HPMPC, 603 Kenya, lymphomas and leukemias in,
Interferon, 153, 299-300
HPV. See Human papillomavirus 249-255
alpha, 600
Human dermal fibroblasts, 720-724 Keratin, 235
basal cell carcinoma and, 58-59
Human ehrlichiosis, 618-619 Keratoacanthoma, 851-853
for melanoma, 872-874
Human immunodeficiency virus. See Keratocheilia, 669-670
HIV infection Interleukin-2 (IL-2), 811-815 Keratoderma
Human papillomavirus (HPV) Interleukin-4 (IL-4), 854-856 climactericum, 375
in condylomata acuminata, 209-211, Internal malignancy, 749-755 palmoplantar, 645-646, 669-670
297-300 International Committee of
Ketoconazole
in women, 370 Dermatology, 884
for cutaneous leishmaniasis,
Human parvovirus B19, 119 International Foundation for
120-121, 495-497
Hutchinson, Sir Jonathan, 211 Dermatology, 514-515, 884 for oral candidosis, 762-763
HV. See Hypersensitivity vasculitis International Journal of Dermatology, for subcutaneous phycomycosis,
224-225
Hydroalcoholic human placental extract, 145-146
61-65 International Society of Dermatology,
for tinea versicolor, 504—505, 613-614
223-225
Hyperpigmentary disorders, 75-82 Ki-1 positive anaplastic large cell
International Symposium (Acapulco,
Hyperplasia, 267-269 lymphoma, 790-793
Mexico), 740-745
Hypersensitivity vasculitis (HV), Klebsiella pneumoniae, 216-217
Interstitial pneumonitis, 354-355
786-789 Klippel-Trenaunay-Weber syndrome
Hypertension, 696-698 lontophoresis, 53-56 (KTWS), 717-718
Hypertrichosis lanuginosa acquista, 7 Irradiation protection, 808-810 Koebner phenomenon, 452, 755
Hypertrophic lichen planus, 70 Isotopic response, 341-347 Kroner, Alfons, 817
Hypertrophic scars, 506-509 Israeli neonates, birthmarks in, 704-706 KTWS. See Klippel-Trenaunay-Weber
Italy, larva migrans in, 464-465
Hypoderma lineatum, 624-626 syndrome
Hypohydrosis, 30-31 Itching, 821 Kuwait, cutaneous leishmaniasis in,
Hypomelanosis, 595-596 Ito, Yu, 817-818 495-497
Hypopigmentation, 824 Itraconazole
Hypopigmented macules, 390-392 for chromoblastomycosis, 804-807 Langerhans’ cells, 580-582
for cutaneous leishmaniasis, 295 Large-cell lymphoma, 593-594,
Ichthyosis, 752 hepatotoxicity and, 589 790-793
Idiopathic hypersensitivity vasculitis, in onychomycosis, 138-142, 286-287 Larva migrans, 464-465, 570-571
786-789 for oral candidosis, 762-763 Laser, 42-47, 48-49, 300
Idiopathic palmar fasciitis, 658-660 for phaeohyphomycosis, 563-565 Latin America, psoriasis in, 583-588
Idoxuridine, 599 for tinea pedis, 122-124 Latvia, Medical Academy of, 67-68
IgA autoantibodies, 591-592 for tinea versicolor, 498-499, 614 Leg ulcer, 696-698
889
International Journal of Dermatology
Vol. 34, No. 12, December 1995
Leishman Donovan bodies, 85, 86 profundus, 357-358 Methotrexate, 678
Leishmania amazonensis, 477 systemic, 330-332 MHE. See Malignant
Leishmania braziliensis, 114-115, Lupus vulgaris, 147 hemangioendothelioma
303-306 Lymphoma Miconazole
Leishmania donovani, 85, 88-89, cutaneous, 535-537, 622-623, in inflammatory dermatomycoses,
303-306 772-773 125-128
Leishmania mexicana, 303-306 Hodgkin’s, 752, 755 for oral candidosis, 763
Leishmaniasis, 16 internal malignancy and, 749-750 Microabscess cells, 535-537
classification of, 303-306 in Kenya, 249-255 Microflora, 76
post-kala-azar dermal, 85-89, 668-669 large cell, 593-594, 790-793 Microsporum audouini, 525-528
visceral, 114-115 Microsporum lanosum, 525-528
See also Cutaneous leishmaniasis Macronutrients, 400 Microwave treatment, 209-211
Leishmania tropica, 303-306 Majocchi’s granuloma, 489 Milia, 193-194
Lentiginous nevus, 637-638 Malignancy Mineral springs, 31, 33
Lentigo maligna, 78-79 internal, 749-755 Minoxidil, 154, 470-472
Leprosy, 214-215 See also Cancer; Carcinoma; Tumors Mixed tumors, 782-785
histoid, 777-781 Malignant eccrine acrospiroma, 271-273 Mongolian spots, 704-706
ofloxacin for, 666-668 Malignant hemangioendothelioma Mononucleosis
(MHE), 811-815 granuloma annulare and, 40-41
umbilicated lesions in, 295-296
Malignant melanoma infectious, 220-221
Leser-Trélat sign, 753
azelaic acid and, 79-80 Moulage
Lesions
conjunctival, 349-353 in Japan, 817-820
discoid lupus erythematosus, 357-358
in Singapore, 773, 775 wax medical, 219
purpuric papulonodular, 190-192
in speckled lentiginous nevus, Mouth, 483-487
umbilicated, 295-296
637-638 See also Lips
Leukemia
in Turner’s syndrome, 823 MRG. See Median rhomboid glossitis
cutaneous metastases and, 749-750
Malignant syphilis, 403-406 MTS. See Muir-Torre syndrome
mucocutaneous manifestations of,
249-255 Malnutrition, 13-14 Mucocutaneous manifestations
MaltaDerm ‘94, 365-367 HIV/AIDS related, 416-419
myelogenous, 323-328, 755
Massa, Nicholas, 143 of lymphomas and leukemias,
Leukoplakia
Mast cells, 1-8 249-255
candidal, 760-761, 763
scabies and, 186-189 Muir-Torre syndrome (MTS), 751
hairy, 420-423
Mastocytosis, 6 Multicentric reticulohistiocytosis, 755
Lichen sclerosus et atrophicus, 369,
Matthioli, Peter Andrew, 10 Multifocal candidosis, 761
373-374
Median nail dystrophy, 799-800 Multiple endocrine neoplasia syndrome
Lichen spinulosus, 670-671
Median rhomboid glossitis (MRG), 761, (MEN Ill), 751
Lifestyle, 398-401
763 Multiple giant disseminated pyogenic
Linear basal cell carcinoma, 488
Medical Academy of Latvia, 67-68 granuloma, 707-709
Linear IgA dermatosis, 591-592
Melanocytic nevi, 704-706 Multiple hamartoma syndrome. See
Lipid-lowering agents, 153 Melanoma Cowden’s syndrome
Lipodystrophy, 36-37 Multiple myeloma, 754
conjunctival, 349-353
Lips, 833 interferon for, 872-874 Mumia, 566, 641
Lithium, 153-154 nodular, 857-858 Mummy (drug), 566, 641
Liver cirrhosis, 651-652 See also Malignant melanoma Mummy (Egyptian), 235
Locus minoris resistentiae, 346 Melasma, 78 Mycobacterioses, 744-745
Loeffler’s syndrome, 570-571 Melkersson-Rosenthal syndrome, Mycoses
Lues maligna. See Malignant syphilis 830-832 deep, 742-744
Lupus band test, 170-173 MEN III. See Multiple endocrine superficial, 741-742
Lupus erythematosus neoplasia syndrome See also Mycosis fungoides
cutaneous, 354-355, 480-482 Menopause, 373 Mycosis fungoides
direct immunofluorescence and, Metastases, 749-750 follicular mucinosis and, 867-869
480-482 Metastatic adenocarcinoma, 360-362 large-cell lymphoma and, 593-594
discoid, 170-173, 357-358 Metchnikoff, Elie, 407 in Singapore, 770, 772
890
Subject Index
Myelogenous leukemia, 323-328, 755 Nodular melanoma, 857-858 Papulonecrotic tuberculid, 217-219
Myeloma, 754 Nodular prurigo, 699 Papulonodular lesions, 190-192
Myiasis, 624-626 Nondermatophytes, 521-524 Paraben, 21-22
Non-Langerhans cell histiocytosis, Paracelsus, Theophrastus, 133
NADPH cofactor, 722 106-111 Paracoccidioidomycosis, 743
Naegeli-Franceschetti-Jadassohn Nurses, 229-230 Paraneoplastic pemphigus (PNP), 754
syndrome, 30-31 Nutritional dermatoses, 11-16 Paraneoplastic syndromes, 749-750,
Nagayasu, Shuichi, 818 752-755
Nail(s) Odors, 92 Paraquat
cosmetic treatment of, 372 Ofloxacin, 666-668 burns from diquat and, 23-24
dystrophy, 799-800 Old age skin cancer in workers, 466-469
terminology, 607-610 menopause and, 373 Parasitoses, 744
yellow, 493-494 syphilis in, 38-39 Paresis, 91
Neck congestion, 622-623 Oligodeoxynucleotides, 603 Paronychia, 385-386
Necrolysis Onychomycosis Partial lipodystrophy (PL), 36-37
epidermal, 801-803 bifonazole for, 500-502 Pautrier’s microabscess cells, 535-537
toxic epidermal, 816 itraconazole versus terbinafine for, PCNA. See Proliferating cell nuclear
Necrolytic migratory erythema. 138-142, 286-287 antigen
See Glucagonoma syndrome nondermatophytes in, 521-524 PCR. See Polymerase chain reaction
Necrosis, 755 types of, 607-608 Pearly penile papules, 425-426
Nehushtan, 20, 168-169, 768-769 OP. See Orbital pseudotumor Pellagra, 499, 503
Neisser, Albert, 137, 817 Oral candidosis, 759-764 Pemphigus
Neonates, 704-706 in HIV, 761-764 foliaceus, 794-795
itraconazole and ketoconazole for,
Neoplasms vegetans, 865-866
762-763
of epithelial germ, 782-785 vulgaris, 181-184, 754
Oral contraceptives, 154
internal malignancy and, 749-755 pulse therapy in, 438-441, 875-882
Oral hairy leukoplakia, 761-762
Nerves, 837-840 Penicillin, 627-629
Oral photochemotherapy, 206-207
Neurofibromatosis, 751 Penicillium marneffei, 743
Oral thrush, 759, 762
Neurogenic inflammation, 685-690 Penile papules, 425-426
Orbital pseudotumor (OP), 34-35
Neuropeptides, 457-458, 685-690, Peptides, 686-690, 694
Orf virus immunity, 644
694-695 Perforating collagenosis, 196-197
Orofacial granulomatosis, 830-832
Neurotic excoriations, 373 Perianal basal cell carcinoma, 427
Osteogenic sarcoma, 861-862
Neurotrophic theory, 239 Perioral contact dermatitis, 72-73
Oxford University, 232
Neutrophil functions, 78 Periungual telangiectasias, 199-200
Oxiconazole, 614-615
Neutrophilic dermatoses, 323-328, Perlche, 760, 763
797-798 Peutz-Jeghers syndrome, 751
PA. See Primary anetoderma
Neutrophilic pleocytosis, 73-74 Peyronie’s disease, 646
Nevoid basal cell carcinoma syndrome, Paecilomyces, 364 PS3 protein, 280-282
Paget’s disease, 374-375
750 pH, 721
extramammary, 715-716, 750, 773
Nevus, 212-213 Phaeohyphomycosis, 563-565
Painful bruising syndrome. See
atypical, 630-632 Pharmaceuticals. See Drugs
Autoerythrocyte sensitization
cerebriform intradermal, 634 syndrome Photochemotherapy, 206-207
congenital, 704-706, 825-828, Photocontact dermatitis, 381
Palmar fasciitis, 658-660
863-864 Palmoplantar keratoderma, 645-646, Photodamage, 466-469, 580-582
lentiginous, 637-638 669-670 Phycomycosis, 145-146
sebaceus, 538-541 Palpable purpura (PP), 787-788 Pigmentation, 96
Spitz, 863-864 Pan American Health Organization, 515 dermatoses, 30-31
Nicotinamide, 434-437 Pangeria. See Werner’s syndrome disorders, 78
Nigeria, nutritional dermatoses in, 11-16 Papillomatosis, 567-568 hypopigmented macules, 390-392
Nipple, 374-375 Papua New Guinea, psychiatric placental extract and, 61-65
Nitric oxide, 294 disorders in, 244-248 reticulate, 219-220
Nodular fat necrosis, 755 Papules, 425-426 Pigmented eccrine poroma, 857-858
International Journal of Dermatology
Vol. 34, No. 12, December 1995
Pigmented purpura, 846-850 Prurigo Pyogenic granuloma, 707-709
Pilomatricoma, 144, 829 actinic, 363-364, 380-383 Pyostomatitis vegetans, 656-657
Pimples, 359 nodular, 699
Pityriasis lichenoides et varioliformis Pseudomonas aeruginosa, 647-649 Quality of life, 700-703
acuta, 642-644 Pseudo-pyostomatitis vegetans, 656-657
Pityriasis rotunda, 755 Psoralen ultraviolet A (PUVA), 680-682, Radiation therapy, 320
Pityrosporum orbiculare, 611-615 808-810 RAPK. See Reticulate acropigmentation
PKDL. See Post-kala-azar dermal Psoriasis, 8 of Kitamura
leishmaniasis acquired, 448-449 Rats, 470-472
PL. See Partial lipodystrophy adhesion molecules in, 510-512 Raynaud’s disease, 329
Placental extract, 61-65 age and gender differences in, Reactive perforating collagenosis,
Plague, 195 700-703 196-197
Plaque psoriasis, 519-520 antithyroid thioureylenes for, Reepithelialization, 696-698
Plasminogen activators, 696-698 280-282 Regional Dermatology Training Centers,
Pleocytosis, 73-74 blue lagoon and, 695 514-515
Pneumocystis carinii, 529 cyclosporine for, 583-588 Research, 617, 620-621
Pneumonitis, 354-355 induced, 449-451 Respiratory tract, 639-641
PNP. See Paraneoplastic pemphigus in Latin America, 583-588 Reticulate acropigmentation of
Poison ivy, 277 neuropathogenesis and Kitamura (RAPK), 80
Polymerase chain reaction (PCR), 209-211 neuropharmacology of, Reticulated papillomatosis, 567-568
Polymorphous light eruption, 381 685-690 Reticulate pigmentary dermatosis,
Polymyxin B, 572-573 pemphigus foliaceus and IgA 30-31, 219-220
nephropathy in, 794-795
Polypeptides, 694 Reticulohistiocytosis, 755
plaque, 519-520
Porcine skin, 42-47 Retinoids, 154, 679
psychoneuroimmunology and, 685
Poroma, 857-858 Retroviridae, 308
psychosocial impact of, 101-105
Porphyria cutanea tarda, 755 Rheumatoid arthritis, 148
quality of life and, 700-703
Port-wine stains, 48—52, 705-706 Rheumatoid factor, 40-41
research models for, 448-453
Postadolescent acne, 372 Rhinophyma, 213
skin grafts, 451-452
Post-kala-azar dermal leishmaniasis Rhomboid glossitis, 761, 763
therapeutic perspectives in, 456-459
(PKDL), 85-89, 668-669 Rhus dermatitis, 769, 789
topical therapy for, 673-682
Postoperative pyoderma gangrenosum, Rocky Mountain spotted fever, 618-619
647-649 treatment at Dead Sea clinic, 134-136
Rowell’s syndrome, 635-636
PP. See Palpable purpura PSS. See Progressive systemic sclerosis
Rush, Benjamin, 537
Pregnancy, 370-371, 443-444 Psychiatric disorders, 244-248
Presuturing, 590 Psychoneuroimmunology, 456, 685
Salicylic acid, 664
Primary anetoderma (PA), 34-35 Psychotic reaction, to procaine
Salmon patches, 705-706
Primary cutaneous aspergillosis, 551-552 penicillin, 627-629
Sarcoidosis, 824
Primary cutaneous histoplasmosis, Pulse therapy
Sarcoma
558-561 for pemphigus, 438-441, 875-882
osteogenic, 861-862
Privacy, 231-232 in progressive systemic sclerosis,
Procaine penicillin, 627-629 726-728 See also Kaposi’s sarcoma
Purple coloring, 430, 509 Scabies, 186-189
Progesterone dermatitis, 372-373
Progressive pigmented purpura, Purpura, 787-788, 846-850 Scalp, 148, 429-430
846-850 Purpuric papulonodular lesions, 190-192 osteogenic sarcoma of, 861-862
Progressive systemic sclerosis (PSS), Pustular dermatosis, 148 pemphigus vegetans of, 865-866
726-728 Pustulosis, 263-265 tinea versicolor of, 533-534
Proguanil, 154 PUVA. See Psoralen ultraviolet A Scars, 506-509
Proliferating cell nuclear antigen PUVASOL, 203-205 Schamberg’s disease, 846-850
(PCNA), 280-282 Pyoderma gangrenosum Schaudinn, Fritz, 208
Propionate cream, 203-205 gastric carcinoma and, 713-714 Schistosomiasis, 703
Propylthiouracil, 519-520 Klippel-Trenaunay-Weber syndrome Scirrhous carcinoma, 293-294
Protein-energy malnutrition, 13-14 as, 717-718 Scleroderma, 6-7
Protothecosis, 554-555, 766-767 recurring postoperative, 647-649 Sclerosis, 726-728
892
Subject Index
Scopulariopsis brevicaulis, 521, 523, 529 Speckled lentiginous nevus, 637-638 Paracelsus on, 137
Scytalidium dimidiatum, 521, 523 Spider silk, 290-292 Schaudinn on, 208
Scytalidium hyalinum, 521, 523 Spitz nevus, 863-864 secondary, 240-243
SDS-PAGE. See Sodium dodecy] sulfate- Squamous cell carcinoma Virchow on, 292
polyacrylamide gel from hypertrophic lichen planus, 70 Syringomas, 193-194
electrophoresis
interferon and, 58-59 Systemic lupus erythematosus (SLE)
Seborrheic dermatitis, 213
internal malignancy and, 753 acne in, 338-340
Secondary syphilis, 240-243
in Kauai, Hawaii, 393-397 basement membrane phenomenon in,
Selenium, 400
in Singapore, 770-772 330-332
Serbia, medical needs in, 883-884
surgery for, 17-18 in Japan, 333-336
Seroconversion syndrome, 238-239 Staphylococcus aureus, 760 lupus band test in, 170-173
Serratia marcescens, 647-649
Stature, 30-31 Systemic sclerosis, 726-728
Short stature, 30-31
Stavudine, 601
Silicone, 506-509 Steatocystoma multiplex, 429-430 TAD. See Transient acantholytic
Singapore, skin cancer in, 770-776 Steroid-pulse therapy. See Pulse therapy dermatosis
Sister Mary Joseph nodule, 750 Stewart, William D., 368 Taenia solium, 575, 577, 578, 652
Skin Still’s disease, 490-492 Takano, Ryoichi, 817-818
cancer Stomatitis, 760, 763 Tars, 677-678
in next century, 445-447
Strawberry hemangiomas, 705-706 Tattoos, 237
in paraquat workers, 466-469 Streptococcal infection, 461-463, Telangiectasia, 751-752
in Singapore, 770-776 642-644 Telogen effluvium, 150
diseases, 227-228, 853 Streptococcus pyogenes, 461-463 TEN. See Toxic epiderma necrolysis
androgen-related, 720-724 Stress-related diseases, 456-457, 458 Terbinafine
coal tar for, 60 Subcutaneous dirofilariasis, 274-276 for Majocchi’s granuloma, 489
of Don Quixote, 212-215 Subcutaneous phaeohyphomycosis, in onychomycosis, 138-142,
in Egyptian mummy, 235 563-565 286-287
eruptions, 379 Subcutaneous phycomycosis, 145-146 Tetracyclines, 567-568
grafts, 451-452 Substance P, 685-690, 694 Thallium, 154
pigmentation, 30-31, 61-65, 96, Sulfasalazine, 154 Thin-layer chromatography (TLC), 63-64
390-392 Sulfate proteoglycan, 630-632 Thioureylenes, 280-282
porcine, 42-47
Sunglasses, 808-810 13-ClS-retinoic acid, 733-734
See also specific conditions and diseases Superficial migratory thrombophlebitis. Tibetan medicine, 834-836
SLE. See Systemic lupus erythematosus See Trousseau’s sign Tincture of benzoin dermatitis, 716
Smallpox, 214 Superficial mycoses, 741-742 Tinea, 213-214
Smell, 92 Surgical excision, 300 Tinea pedis, 122-124
Smoking, 401 Sweet’s syndrome, 755 Tinea versicolor, 611-615
Soap, 198 and cerebrospinal fluid, 73-74 fluconazole versus itraconazole for,
Society News Syphilis 498-499, 614
International Committee of Bethencourt on, 124 ketoconazole for, 504-505, 613-614
Dermatology, 884 Bloch on, 424 of scalp, 533-534
International Foundation for Diday on, 115 TLC. See Thin-layer chromatography
Dermatology, 514-515, 884
in Don Quixote, 214 Tobacco, 732
International Society of Dermatology,
Fernel on, 270 Topical corticosteroids, 673-676
223-225
Fournier on, 428 Topical cyclosporine, 678-679
obituary, 368, 746-747
Fracastoro and, 735-739 Topical methotrexate, 678
Regional Dermatology Training
Hutchinson on, 211 Topical PUVA therapy, 680-682
Centers, 514-515
malignant, 403-406 Topical retinoids, 679
Sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS- Massa on, 143 Topical tretinoin, 580-582
PAGE), 63-64 Martthioli on, 10 Topical trimetrexate, 678
Solar pruritis, 594-595 Metchnikoff on, 407 Toxic epidermal necrolysis (TEN), 816
Solitary keratoacanthoma. See Neisser on, 137 Toxic shock syndrome, 661-663
Squamous cell carcinoma in old age, 38-39 Toxoplasma gondi, 529
893
International Journal of Dermatology
Vol. 34, No. 12, December 1995
Toxoplasmosis, 443 Ultrasonography, 646 Vitiligo, 595-596
Transient acantholytic dermatosis Ultraviolet A (UVA), 680-682, 808-810 childhood, 203-205
(TAD), 113 Umbilicated lesions, 295-296 dermal nerves in, 837-840
Tretinoin, 53-56, 580-582 UPA. See Urokinase-type plasminogen oral photochemotherapy in, 206-207
Trichophyton mentagrophytes, 522, 529 activator Von Recklinghausen’s
Trichophyton rubrum, 522, 525-528, Urokinase-type plasminogen activator neurofibromatosis, 751
529, 608 (UPA), 696-698 Vulva, 232-233
Trichophyton schoenleinii, 525-528 Urticaria, 823-824 Vulval schistosomiasis, 703
Trichophyton tonsurans, 525-528, 529 UV. See Vasculitic ulcer
Trichophyton violaceum, 525-528, 529 UVA. See Ultraviolet A Wax medical moulages, 219
Trichotillomania, 370 See also Moulage
Tricoadenoma of Nikolowski, 711-712 Vaccines, 601-602 Wegener’s granulomatosis, 870-871
Tricyclic antidepressants, 154-155 Valaciclovir, 602 Weight, 401
Trifluridine, 599 Valproic acid, 155 Werner’s syndrome, 752
Trimethylaminuria. See Fish-odor Varicelliform eruption, 854-856 Wiskott-Aldrich syndrome, 752
syndrome Vasculitic ulcer (UV), 787-788 Women
Trimetrexate, 678 Vasculitis, 786-789 dermatologic diseases of, 369-376
Tripe palms, 754 Vasoactive intestinal peptide (VIP), in dermatology, 221-222, 387-389,
Tropical diseases, 226-234 686-6906,9 4 531-532
Trousseau’s sign, 752 Venous hypertension, 696-698 gender and tropical diseases,
Tuberculosis Venous leg ulcer, 696-698 226-234
cutaneous, 26-29 Vertex aplasia, 590 Wound healing, 7-8, 42-47
global strategy, 442 Vidarabine, 600
Tumors, 753 VIP. See Vasoactive intestinal peptide Xanthogranuloma, 653-655
azelaic acid and, 77-78 Virchow, Rudolf, 292
basal cell carcinoma, 319-320 Visceral leishmaniasis, 114-115 Yellow nail, 493-494
mixed, 782-785 Vitamin C, 400-401
Turner’s syndrome, 823, 840 Vitamin D, 740 Zalcitabine, 601
Vitamin D3, 679 Zinc deficiency, 651-652
Ulcers, 239 Vitamin E, 401, 506-509
vasculitic, 787-788 Vitamin K1, 201